125 related articles for article (PubMed ID: 23322666)
1. ¹⁸F-fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: a prospective, randomized, controlled clinical study.
Frost ML; Moore AE; Siddique M; Blake GM; Laurent D; Borah B; Schramm U; Valentin MA; Pellas TC; Marsden PK; Schleyer PJ; Fogelman I
J Bone Miner Res; 2013 Jun; 28(6):1337-47. PubMed ID: 23322666
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of teriparatide on regional bone formation using (18)F-fluoride positron emission tomography.
Frost ML; Siddique M; Blake GM; Moore AE; Schleyer PJ; Dunn JT; Somer EJ; Marsden PK; Eastell R; Fogelman I
J Bone Miner Res; 2011 May; 26(5):1002-11. PubMed ID: 21542003
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.
Frost ML; Cook GJ; Blake GM; Marsden PK; Benatar NA; Fogelman I
J Bone Miner Res; 2003 Dec; 18(12):2215-22. PubMed ID: 14672357
[TBL] [Abstract][Full Text] [Related]
4. Differences in regional bone perfusion and turnover between lumbar spine and distal humerus: (18)F-fluoride PET study of treatment-naïve and treated postmenopausal women.
Frost ML; Blake GM; Cook GJ; Marsden PK; Fogelman I
Bone; 2009 Nov; 45(5):942-8. PubMed ID: 19660584
[TBL] [Abstract][Full Text] [Related]
5. Effects of alendronate on bone metabolism in glucocorticoid-induced osteoporosis measured by 18F-fluoride PET: a prospective study.
Uchida K; Nakajima H; Miyazaki T; Yayama T; Kawahara H; Kobayashi S; Tsuchida T; Okazawa H; Fujibayashi Y; Baba H
J Nucl Med; 2009 Nov; 50(11):1808-14. PubMed ID: 19837766
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
7. The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover.
Frost ML; Cook GJ; Blake GM; Marsden PK; Fogelman I
J Clin Densitom; 2007; 10(1):46-54. PubMed ID: 17289526
[TBL] [Abstract][Full Text] [Related]
8. Differences in regional bone metabolism at the spine and hip: a quantitative study using (18)F-fluoride positron emission tomography.
Puri T; Frost ML; Curran KM; Siddique M; Moore AE; Cook GJ; Marsden PK; Fogelman I; Blake GM
Osteoporos Int; 2013 Feb; 24(2):633-9. PubMed ID: 22581294
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity in detection of a porcine high-turnover osteopenia after total gastrectomy by dynamic 18F-fluoride ion PET and quantitative CT.
Piert M; Zittel TT; Jahn M; Stahlschmidt A; Becker GA; Machulla HJ
J Nucl Med; 2003 Jan; 44(1):117-24. PubMed ID: 12515885
[TBL] [Abstract][Full Text] [Related]
10. Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism.
Frost ML; Blake GM; Park-Holohan SJ; Cook GJ; Curran KM; Marsden PK; Fogelman I
J Nucl Med; 2008 May; 49(5):700-7. PubMed ID: 18413385
[TBL] [Abstract][Full Text] [Related]
11. Odanacatib treatment affects trabecular and cortical bone in the femur of postmenopausal women: results of a two-year placebo-controlled trial.
Engelke K; Fuerst T; Dardzinski B; Kornak J; Ather S; Genant HK; de Papp A
J Bone Miner Res; 2015 Jan; 30(1):30-8. PubMed ID: 24898537
[TBL] [Abstract][Full Text] [Related]
12. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
Blake GM; Siddique M; Frost ML; Moore AE; Fogelman I
Bone; 2011 Sep; 49(3):537-42. PubMed ID: 21689803
[TBL] [Abstract][Full Text] [Related]
13. Semiautomatic region-of-interest validation at the femur in (18)F-fluoride PET/CT.
Puri T; Blake GM; Curran KM; Carr H; Moore AE; Colgan N; O'Connell MJ; Marsden PK; Fogelman I; Frost ML
J Nucl Med Technol; 2012 Sep; 40(3):168-74. PubMed ID: 22892275
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
Frost ML; Fogelman I; Blake GM; Marsden PK; Cook G
J Bone Miner Res; 2004 Nov; 19(11):1797-804. PubMed ID: 15476579
[TBL] [Abstract][Full Text] [Related]
15. Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
Leder BZ; O'Dea LS; Zanchetta JR; Kumar P; Banks K; McKay K; Lyttle CR; Hattersley G
J Clin Endocrinol Metab; 2015 Feb; 100(2):697-706. PubMed ID: 25393645
[TBL] [Abstract][Full Text] [Related]
16. Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial.
Amstrup AK; Sikjaer T; Heickendorff L; Mosekilde L; Rejnmark L
J Pineal Res; 2015 Sep; 59(2):221-9. PubMed ID: 26036434
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.
Ettinger B; San Martin J; Crans G; Pavo I
J Bone Miner Res; 2004 May; 19(5):745-51. PubMed ID: 15068497
[TBL] [Abstract][Full Text] [Related]
18. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
19. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
